T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Paclitaxel|DRUG: Trastuzumab emtansine
Sponsor: Dana-Farber Cancer Institute